Just one quick question on the Noida unit. Are there any insurance empanelment pending? Or are we done with all the empanelment in the Noida unit?
Great. Just one more follow-up question on the Noida unit. Could you help me with the ARPOB range of this facility currently?
Sir, a few questions or clarifications on upcoming projects. Could you help us with the time line for the DLF project and the Pitampura project?
Got it. And just a follow -up on these two projects, sir. Will be sharing rent or will be sharing part of revenues in both these projects?
Hi. Thank you for the opportunity. Just hopping on the margins guidance. I understand we want to be conservative. But if I just look at the mix of assets that we are commissioning in FY'27, which are more spokes than hubs, would it be fair to assume margin accretion in F Y'27 would be sharper than the accretion we have witnessed in FY'26 itself?
Sure. Next question I had was we already have a cash balance of almost INR 280-odd INR 300- odd crores. And I think by the looks of it, assuming the capex that you have just outlined, we should be able to add another INR 150 crores to INR 200 crores odd number in the next year as well. Any plans on deploying this balance for any inorganic expansion? And how does management think about this deploying this cash on books?
So, I have a few questions. First question, is there any particular reason why our gross margins have contracted despite strong growth in wellness in the current quarter?
Okay. What I wanted to check was, is this on the back of any rupee depreciation, which could reverse in the coming quarters? Or should we structurally consider this to be the new normal in gross margin?
So just as a clarification, so we have only in terms of our guidance of hub additions, we have only added Bangalore to the number. So we were initially planning to add 12 hubs in '25, '26. Now we plan to add 14, which is an inclusion of Bangalore. Would that be correct?
Correct. So 3 we have already added, 9 we are adding, 11 is what we'll be adding in entire of FY '26. I'm just trying to understand that?
My first question is on the mature hospitals. Any comment on why volume growth has been -- volumes have been muted for this portfolio?
Sure. A follow-up on this, sir. So, our surgical mix would have actually deteriorated in the current quarter. And so what would explain the jump in ARPOB or ARPPs, given that surgical mix would have actually reduced?
Hi, thank you for the opportunity. My question is on network expansion. Are we looking to aggressively add labs in the next 1 or 2 years or do we think that the current lab network should suffice our growth plans in this period?
Just a follow up on this , sir. Would we see an increase in our PSCs as well commensurate to what we have seen in the current year? The reason why I ask is this, our lab utilizations surely seem to be going up. And would that continue in your view?
If you could just help me with the number of labs you have already added in the nine months ended for this current year?
I have a follow -up question on that. Has the Delhi region grown on the back of network expansion or would this be a sort of an SSG kind of growth that we have witnessed over the last two quarters?
Great. Ma'am I just wanted to ask a question on the capex the additional hubs that we have sort of commissioned, will they be part of our budgeted planning and are they included in our capex plans of about 250 odd crores that we will deploy in the current year?
Sure. So, the question that I basically had was does our capex of 250, capex guidance of about INR250 odd crores for FY25 remain intact?